Amylyx director granted 24,372 stock options
Amylyx Pharmaceuticals director Daphne Quimi received a stock option grant covering 24,372 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amylyx Pharmaceuticals director Daphne Quimi received a stock option grant covering 24,372 shares of Common Stock. The option has an exercise price of $14.31 per share and expires on June 3, 2036. It vests in full on the earlier of June 4, 2027 or the next annual meeting, subject to her continuous service, and represents her entire reported option position in this filing.
Insider Trade Summary
Grant/Award: 24,372 shares
Grant/Award
1 txn
Insider
Quimi Daphne
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 24,372 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 24,372 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
Option grant size: 24,372 options
Exercise price: $14.31 per share
Expiration date: June 3, 2036
+3 more
6 metrics
Option grant size
24,372 options
Stock Option (right to buy) granted to director Daphne Quimi
Exercise price
$14.31 per share
Conversion or exercise price of granted stock options
Expiration date
June 3, 2036
Option expiration for 24,372-share grant
Vesting date
Earlier of June 4, 2027 or next annual meeting
Full vesting subject to continuous service
Total options after grant
24,372 options
Total derivative securities following transaction
Transaction price per option
$0.00
Grant/award acquisition, no cash paid for options
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 14.3100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to this option shall vest in full upon the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Amylyx Pharmaceuticals (AMLX) report for Daphne Quimi?
Amylyx Pharmaceuticals reported that director Daphne Quimi received a stock option grant for 24,372 shares of Common Stock. The options are part of her compensation and give her the right to buy shares at a fixed price in the future.
What is the exercise price of Daphne Quimi’s new Amylyx (AMLX) stock options?
The granted stock options allow Daphne Quimi to purchase 24,372 Amylyx shares at an exercise price of $14.31 per share. This fixed price means she can later buy shares at that level regardless of future market prices.
When do Daphne Quimi’s Amylyx (AMLX) stock options vest and become exercisable?
The options vest in full on the earlier of June 4, 2027 or the date of the next annual shareholder meeting. Vesting is conditional on Daphne Quimi maintaining continuous service with Amylyx through that vesting date.
When do Daphne Quimi’s newly granted Amylyx (AMLX) stock options expire?
The stock options granted to Daphne Quimi expire on June 3, 2036. After this expiration date, any unexercised portion of the 24,372-share option grant will lapse and can no longer be used to purchase Amylyx stock.
How many Amylyx (AMLX) derivative securities does Daphne Quimi hold after this Form 4 transaction?
Following this transaction, Daphne Quimi holds 24,372 stock options according to the filing. This matches the number of options granted, indicating this grant constitutes her reported derivative position in this particular Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates